<qa>  What is the name of the immunotherapy that is allowed in breast and prostate cancer?16. Any anti-cancer treatment within 2 weeks of initiating treatment as part of this trial, including cytotoxic chemotherapy e.g. temozolomide, radiation therapy single fraction or fractionated, and biological therapies e.g. mono-clonal antibodies, tyrosine kinase inhibitors, interferon. Hormonal therapies e.g. in breast and prostate cancer are allowed both prior to and during treatment. 